Axel Hinke

Years Active: 2018-2024
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas Jens Ettrich, Dominik Paul Modest, Marianne Sinn, Jana K Striefler, Bernhard Opitz, Thorsten Goetze, Eike Gallmeier, Stefan Angermeier, Ludwig Fischer von Weikersthal, Lutz Jacobasch, Dirk Waldschmidt, Michael Niedermeier, Michael Sohm, Andreas W Berger, Giulia Manzini, Uli Fehrenbach, Timo Alexander Auer, Clarissa Hosse, Daniel Vogele, Disorn Sookthai, Marina Schaaf, Rainer Muche, Axel Hinke, Thomas Seufferlein, Lukas Perkhofer
Nanoliposomal Irinotecan With Fluorouracil and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Cholangiocarcinoma: A Phase II Study of the AIO Hepatobiliary-YMO Cancer Groups (NIFE-AIO-YMO HEP-0315). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Peter Dall, Thorsten Koch, Thomas Göhler, Johannes Selbach, Andreas Ammon, Jochen Eggert, Nidal Gazawi, Daniela Rezek, Arthur Wischnik, Carsten Hielscher, Nicolas Schleif, Ursula Cirrincione, Axel Hinke, Gabriele Feisel-Schwickardi
Trastuzumab without chemotherapy in the adjuvant treatment of breast cancer: subgroup results from a large observational study. BMC cancer 18 (1) (2018)

Axel Hinke.css-eqlu8i{font-size:small;padding-left:4px;}